2.430USD+2.10%Mkt Cap: 86.39M $P/E: 5.65Today
biote Corp. operates in practice-building business within the hormone optimization space. It trains physicians and nurse practitioners in hormone optimization using bioidentical hormone replacement pellet therapy in men …
Industry Peers
Medical Care FacilitiesIndicators:|
Key Statistics
Company
Market Cap86.39M $
Enterprise Value183.43M $
Revenue (TTM)188.16M $
Gross Profit137.36M $
Net Income (TTM)27.05M $
Revenue/Share6.055 USD
Last Price2.430 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees223
CountryUS
SectorHealthcare
IndustryMedical Care Facilities
ISIN—
Valuation
P/E (Trailing)5.65
P/E (Forward)4.18
PEG—
EV/EBITDA5.58
EV/Revenue0.97
P/S0.45
P/B-1.27
EPS (TTM)0.43
EPS (Forward)0.57
52W Range
1.27033% of range4.750
52W High4.750 USD
52W Low1.270 USD
Profitability
Gross Margin71.46%
Oper. Margin9.78%
EBITDA Margin17.46%
Profit Margin14.07%
ROE-46.20%
ROA25.13%
Growth
Revenue Growth-8.30%
Earnings Growth-83.80%
Cash Flow & Leverage
Operating CF35.19M $
CapEx (TTM)6.86M $
FCF Margin-2.52%
FCF Yield-5.48%
Net Debt103.10M $
Net Debt/EBITDA3.14
Balance Sheet
Debt/Equity-1.88
Current Ratio1.29
Quick Ratio0.45
Book Value/Sh-1.8710 USD
Cash/Share0.1750 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating1.5 (Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)2.732 USD
Upside (mean)+12.4%
Target Range2.000 USD – 3.430 USD
$2.000+12.4% to mean$3.430
# Analysts4
Ownership
Shares Out.30.33M
Float19.63M
Insiders10.39%
Institutions67.38%
Short Interest
Short Ratio1.4d
Short % Float2.52%
Short % Out.1.83%
Shares Short553.64K
Short (prev mo.)1.41M
Technical
SMA 502.139 (+13.6%)
SMA 2002.283 (+6.5%)
Beta1.66
S&P 52W Chg20.25%
Avg Vol (30d)342.79K
Avg Vol (10d)206.09K
Technical Indicators
RSI (14)60.4
MACD0.0541
MACD Signal0.0240
MACD Hist.+0.0302
BB Upper2.558 USD
BB Middle2.156 USD
BB Lower1.755 USD
BB Width37.25%
ATR (14)0.1704 USD
Vol Ratio (20d)0.73x